Ignite Creation Date:
2024-05-06 @ 7:56 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02635230
Status:
UNKNOWN
Last Update Posted:
2020-03-11
First Post:
2015-12-10
Brief Title:
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2
Sponsor:
RD Cardiologie
Organization:
RD Cardiologie
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atrial Fibrillations |
| Heart Valve Prostheses |
| Acute Coronary Syndromes |
| Coronary Artery Diseases |
| Stroke |
| Bleeding |
| Myocardial Infarction |
Keywords:
| Name | View |
|---|---|
| Direct Thrombin Inhibitors | View |
| Atrial Fibrillations | View |
| Heart Valve Prostheses | View |
| Acute Coronary Syndromes | View |
| Percutaneous Coronary Revascularization | View |
| Coronary Artery Bypass Grafting | View |
| Coronary Artery Diseases | View |
| Myocardial Infarction | View |
| Ischemic stroke | View |
| Bleeding | View |
| Thrombosis | View |
| Myocardial Ischemia | View |
| Heart Diseases | View |
| Cardiovascular Diseases | View |
| Embolism and Thrombosis | View |
| Platelet Aggregation Inhibitors | View |
| Aspirin | View |
| Clopidogrel | View |
| Ticagrelor | View |
| Prasugrel | View |
| Antithrombotic treatment | View |
| Oral anticoagulation | View |
| Warfarin | View |
| Dabigatran etexilate mesylate | View |
| Apixaban | View |
| Rivaroxaban | View |
| Direct Factor Xa Inhibitors | View |